Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

226

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

226 results for “Active compounds”

Learn how ShareScore rates datasets ↗
zenodo28/100

Fig. 12 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications

Fig. 12. The newly reported compounds of seco-lignans.

opennotspecifiedOct 2022View details →
zenodo28/100

Fig. 13 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications

Fig. 13. The newly reported compounds of norlignans.

opennotspecifiedOct 2022View details →
zenodo28/100

Fig. 10 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications

Fig. 10. The newly reported compounds of benzofuran lignans.

opennotspecifiedOct 2022View details →
zenodo28/100

Fig. 11 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications

Fig. 11. The newly reported compounds of oxyneolignans and non-oxyneolignans.

opennotspecifiedOct 2022View details →
zenodo28/100

Fig. 5 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications

Fig. 5. The newly reported compounds of arylnaphthalenelactones lignans.

opennotspecifiedOct 2022View details →
zenodo28/100

Fig. 6 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications

Fig. 6. The newly reported compounds of furofuran lignans.

opennotspecifiedOct 2022View details →
zenodo28/100

Fig. 8 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications

Fig. 8. Basic skeletons of neolignans.

opennotspecifiedOct 2022View details →
zenodo28/100

Fig. 3 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications

Fig. 3. The newly reported compounds of tetrahydrofuran lignans.

opennotspecifiedOct 2022View details →
zenodo28/100

Fig. 1 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications

Fig. 1. Basic skeletons of lignans.

opennotspecifiedOct 2022View details →
zenodo28/100

Fig. 9 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications

Fig. 9. The newly reported compounds of biphenyl lignans.

opennotspecifiedOct 2022View details →
zenodo28/100

Fig. 7 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications

Fig. 7. The newly reported compounds of dibenzocyclooctene lignans.

opennotspecifiedOct 2022View details →
zenodo28/100

Fig. 4 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications

Fig. 4. The newly reported compounds of arylnaphthalene lignans.

opennotspecifiedOct 2022View details →
zenodo28/100

Fig. 2 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications

Fig. 2. The newly reported compounds of dibenzylbutane lignans.

opennotspecifiedOct 2022View details →
zenodo28/100

Fig. 5. Experimental ECDs and calculated ECDs for compounds 4–7 in Undescribed specialised metabolites from the endophytic fungus Emericella sp. XL029 and their antimicrobial activities

Fig. 5. Experimental ECDs and calculated ECDs for compounds 4–7.

opennotspecifiedOct 2022View details →
zenodo28/100

Fig. 1 in Structural characterization of prenylated compounds from Broussonetia kazinoki and their antiosteoclastogenic activity

Fig. 1. Chemical structures of compounds 1–19.

opennotspecifiedAug 2021View details →
zenodo28/100

Fig. 1 in Screening of in vitro and in silico α-amylase, α-glucosidase, and lipase inhibitory activity of oxyprenylated natural compounds and semisynthetic derivatives

Fig. 1. Chemical structures of the 23 analysed pure natural and semisynthetic compounds.

opennotspecifiedJul 2021View details →
zenodo28/100

Fig. 2. NOESY correlations for compound 1 and HMBC correlations for compound 2 in Indole alkaloids from the leaves of Ravenia spectabilis engl. with activity against pancreatic cancer cell line

Fig. 2. NOESY correlations for compound 1 and HMBC correlations for compound 2.

opennotspecifiedJun 2021View details →
zenodo28/100

Fig. 6. Perspective ORTEP drawing for compound 4 in Chemical constituents of Psidium guajava leaves and their antibacterial activity

Fig. 6. Perspective ORTEP drawing for compound 4.

opennotspecifiedJun 2021View details →
zenodo28/100

Fig. 10. Proposed biogenetic pathway for compounds 1–13 in Prenylated C -C derivatives from the stems and branches of Illicium ternstroemioides A. C. Smith with antiviral activity

Fig. 10. Proposed biogenetic pathway for compounds 1–13.

opennotspecifiedDec 2021View details →
zenodo28/100

Fig. 7. Relative ATPase activity treated with 21 in Seasonal variation of phenolic compounds in Zostera marina (Zosteraceae) from the Baltic Sea

Fig. 7. Relative ATPase activity treated with 21 in micromolar range.

opennotspecifiedApr 2022View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record